vs
Side-by-side financial comparison of NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC) and Valneva SE (VALN). Click either name above to swap in a different company.
Valneva SE is the larger business by last-quarter revenue ($36.2M vs $23.3M, roughly 1.6× NORTHERN TECHNOLOGIES INTERNATIONAL CORP). NORTHERN TECHNOLOGIES INTERNATIONAL CORP runs the higher net margin — 1.0% vs -54.1%, a 55.1% gap on every dollar of revenue.
Maxar Technologies Inc., was an American space technology company, specializing in geospatial intelligence, Earth observation, and on-orbit satellite servicing, satellite products, and related services. DigitalGlobe and MDA Holdings Company merged to become Maxar Technologies on October 5, 2017.
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.
NTIC vs VALN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $23.3M | $36.2M |
| Net Profit | $237.8K | $-19.6M |
| Gross Margin | 36.0% | 38.9% |
| Operating Margin | 4.0% | -49.5% |
| Net Margin | 1.0% | -54.1% |
| Revenue YoY | 9.2% | — |
| Net Profit YoY | -57.6% | — |
| EPS (diluted) | $0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.3M | — | ||
| Q3 25 | $22.3M | — | ||
| Q2 25 | $21.5M | — | ||
| Q1 25 | $19.1M | — | ||
| Q4 24 | $21.3M | — | ||
| Q3 24 | $23.3M | — | ||
| Q2 24 | $20.7M | — | ||
| Q1 24 | $20.8M | — |
| Q4 25 | $237.8K | — | ||
| Q3 25 | $-1.1M | — | ||
| Q2 25 | $121.8K | — | ||
| Q1 25 | $434.3K | — | ||
| Q4 24 | $561.1K | — | ||
| Q3 24 | $1.8M | — | ||
| Q2 24 | $976.6K | — | ||
| Q1 24 | $1.7M | — |
| Q4 25 | 36.0% | — | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 38.4% | — | ||
| Q1 25 | 35.6% | — | ||
| Q4 24 | 38.3% | — | ||
| Q3 24 | 43.8% | — | ||
| Q2 24 | 38.2% | — | ||
| Q1 24 | 40.0% | — |
| Q4 25 | 4.0% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 4.0% | — | ||
| Q1 25 | -1.7% | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 10.6% | — |
| Q4 25 | 1.0% | — | ||
| Q3 25 | -4.9% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 8.2% | — |
| Q4 25 | $0.03 | — | ||
| Q3 25 | $-0.11 | — | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | $0.04 | — | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $0.19 | — | ||
| Q2 24 | $0.10 | — | ||
| Q1 24 | $0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $72.4M | $221.2M |
| Total Assets | $104.0M | $637.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | — | ||
| Q3 25 | $7.3M | — | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $5.1M | — | ||
| Q4 24 | $5.6M | — | ||
| Q3 24 | $5.0M | — | ||
| Q2 24 | $5.8M | — | ||
| Q1 24 | $4.8M | — |
| Q4 25 | $72.4M | — | ||
| Q3 25 | $72.1M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $69.7M | — | ||
| Q4 24 | $70.2M | — | ||
| Q3 24 | $71.2M | — | ||
| Q2 24 | $68.9M | — | ||
| Q1 24 | $68.4M | — |
| Q4 25 | $104.0M | — | ||
| Q3 25 | $102.7M | — | ||
| Q2 25 | $99.3M | — | ||
| Q1 25 | $93.7M | — | ||
| Q4 24 | $94.0M | — | ||
| Q3 24 | $94.7M | — | ||
| Q2 24 | $89.3M | — | ||
| Q1 24 | $87.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $341.9K | $-26.3M |
| Free Cash FlowOCF − Capex | $-479.7K | — |
| FCF MarginFCF / Revenue | -2.1% | — |
| Capex IntensityCapex / Revenue | 3.5% | — |
| Cash ConversionOCF / Net Profit | 1.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $341.9K | — | ||
| Q3 25 | $-1.4M | — | ||
| Q2 25 | $609.7K | — | ||
| Q1 25 | $803.7K | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.9M | — | ||
| Q1 24 | — | — |
| Q4 25 | $-479.7K | — | ||
| Q3 25 | $-1.4M | — | ||
| Q2 25 | $-171.2K | — | ||
| Q1 25 | $293.1K | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $869.4K | — | ||
| Q1 24 | — | — |
| Q4 25 | -2.1% | — | ||
| Q3 25 | -6.3% | — | ||
| Q2 25 | -0.8% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | — | — |
| Q4 25 | 3.5% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.44× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.01× | — | ||
| Q1 25 | 1.85× | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.99× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTIC
| Inside The USA To Unaffiliated Customers | $7.5M | 32% |
| Natur Tec | $6.0M | 26% |
| Acobal | $3.6M | 15% |
| Other | $2.7M | 12% |
| BR | $2.1M | 9% |
| Zerust OY | $1.4M | 6% |
VALN
Segment breakdown not available.
